Order your free hard copy by adding to cart or you can download an electronic copy for free using the link below
Order your free hard copy by adding to cart or you can download an electronic copy for free using the link below
The document discusses benzimidazole-opioids, synthetic substances with opioid-like effects that are being trafficked and abused, leading to adverse health effects, including fatalities. These substances, which act as mu-opioid receptor agonists, are not approved for medical use in the U.S. and are classified as Schedule I controlled substances. Since 2019, their presence in toxicology cases and drug seizures has significantly increased, posing serious public health and safety risks. The DEA highlights their high potential for addiction, respiratory depression, and the dangers of unregulated distribution.
This Pathways Behavioral Health Education Award Initiative is supported by the Centers for Medicare & Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling BP1-$915,558, BP2-$1,253,012 with 100% percent funded by CMS/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CMS/HHS, or the U.S. Government.
This project is funded under a grant contract with the State of Tennessee,
Department of Mental Health and Substance Abuse Services.


Address
1321 Murfreesboro Pike #155
Nashville, TN 37217
United States
615-780-5901